 |
Deposito minimo $50 Promozione esclusiva |
Il nostro punteggio |
0% commissione |
Are you looking to buy Abbott Laboratories stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NYSE:ABT! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Abbott Laboratories stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière’s disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company’s Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company’s Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.
Volume medio
5,82 milioni di shs
TAPPA DEL MERCATO
$220.85 billion
Borsa valori
NYSE
Compri queste azioni!
|
NOME
|
TICKER
|
INDUSTRIA
|
SETTORE
|
VOLUME
|
COMPRI ORA QUESTE AZIONI
|
|---|---|---|---|---|---|
|
NYSE:ABT
|
Preparati farmaceutici
|
Medico
|
101,708 shs
|
Below is a quick guide on how to buy NYSE:ABT stocks safe, fast and around the world in less than five minutes.
Passo 1: Aprire un conto con eToro – eToro is the best broker to buy Abbott Laboratories shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: caricare il suo ID - Come da regolamento KYC eToro le chiederà di caricare una copia del suo passaporto o della sua patente di guida.
Passo 3: Deposito di fondi - Depositi del denaro nel suo conto eToro appena creato. Può scegliere tra bonifico bancario, e-wallet o carta di debito/credito o Paypal.
Passo 4: Buy Abbott Laboratories – Search for “”NYSE:ABT”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Abbott Laboratories stocks with 0% commission!.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
17 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Abbott Laboratories in the last twelve months. There are currently 1 sell rating, 1 hold rating and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Abbott Laboratories stock.
Wall Street analysts have given Abbott Laboratories a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Abbott Laboratories wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
2 |  | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
3 |  | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NYSE:ABT stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Abbott Laboratories stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Abbott Laboratories stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Poiché eToro è una piattaforma regolamentata, dovrà completare il processo KYC, questa è una pratica standard e richiede solo un paio di minuti. Dovrà fornire un documento d'identità con foto (passaporto, patente) e una prova di indirizzo (bolletta, estratto conto bancario).
Una volta iscritto e verificato il suo conto, dovrà depositare dei fondi. eToro accetta carte di credito/debito, trasferimenti bancari e anche portafogli elettronici. Quindi qualunque sia la sua preferenza ci sarà qualcosa per lei.
Now that you’ve funded your eToro account, just type “NYSE:ABT stocks" nella barra di ricerca nella parte superiore dello schermo e prema "trade".
All that’s left is to buy some NYSE:ABT stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NYSE:ABT is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Abbott Laboratories stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Abbott Laboratories is scheduled to release its next quarterly earnings announcement on Thursday, April 15th 2021.
View our earnings forecast for Abbott Laboratories.
Abbott Laboratories (NYSE:ABT) announced its quarterly earnings data on Tuesday, January, 26th. The healthcare product maker reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.35 by $0.10. The healthcare product maker had revenue of $10.70 billion for the quarter, compared to the consensus estimate of $9.94 billion. Abbott Laboratories had a net margin of 10.50% and a trailing twelve-month return on equity of 18.19%. The firm’s revenue was up 28.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.95 EPS.
View Abbott Laboratories’ earnings history.
Abbott Laboratories’ stock was trading at $78.09 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ABT stock has increased by 59.7% and is now trading at $124.70.
Abbott Laboratories announced a quarterly dividend on Friday, December 11th. Shareholders of record on Friday, January 15th will be given a dividend of $0.45 per share on Tuesday, February 16th. This represents a $1.80 dividend on an annualized basis and a yield of 1.44%. The ex-dividend date is Thursday, January 14th. This is a boost from Abbott Laboratories’s previous quarterly dividend of $0.36.
View Abbott Laboratories’ dividend history.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NYSE:ABT stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Oltre 95% dei fondi dei clienti sono tenuti offline, in depositi freddi, il che è fondamentale per qualsiasi broker che gestisce i suoi beni. Indipendentemente da quanto sia sicura una piattaforma, raccomandiamo di usare 2FA per aggiungere un ulteriore livello di sicurezza al suo conto.
eToro offre agli utenti una serie di caratteristiche per iniziare ad investire il più rapidamente possibile. Hanno una caratteristica relativamente unica chiamata copy trading, che le permette di guadagnare un reddito passivo facendo da specchio a trader esperti, questo le permette di iniziare a guadagnare rapidamente e le dà una migliore comprensione delle strategie usate dai professionisti. Inoltre, eToro permette agli utenti di investire in portafogli gestiti, un portafoglio gestito è una varietà di asset simili raggruppati insieme, che le permette di diversificare il suo conto, riducendo qualsiasi rischio potenziale. Per chi ha esperienza di trading precedente, può investire in mercati al di fuori delle azioni, dato che eToro permette agli utenti di commerciare ETF, materie prime, cripto e indici. Se già investe al di fuori dello spazio del mercato azionario questo può essere molto utile, perché le permette di gestire tutti i suoi investimenti in un solo posto.
Abbott Laboratories pays an annual dividend of $1.80 per share and currently has a dividend yield of 1.45%. Abbott Laboratories has been increasing its dividend for 49 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Abbott Laboratories is 55.56%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Abbott Laboratories will have a dividend payout ratio of 41.10% next year. This indicates that Abbott Laboratories will be able to sustain or increase its dividend.
View Abbott Laboratories’ dividend history.
Abbott Laboratories issued an update on its FY21 earnings guidance on Wednesday, January, 27th. The company provided EPS guidance of at least $5.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.42.
I CFD sono strumenti complessi e comportano un alto rischio di perdere denaro rapidamente a causa della leva. Il 68% dei conti degli investitori al dettaglio perdono denaro quando scambiano CFD con questo fornitore. Deve considerare se capisce come funzionano i CFD e se può permettersi di correre l'alto rischio di perdere i suoi soldi.
17 Wall Street analysts have issued twelve-month price targets for Abbott Laboratories’ stock. Their forecasts range from $94.00 to $140.00. On average, they anticipate Abbott Laboratories’ stock price to reach $121.83 in the next twelve months. This suggests that the stock has a possible downside of 2.3%.
View analysts’ price targets for Abbott Laboratories or view top-rated stocks among Wall Street analysts.
Abbott Laboratories’ management team includes the following people:
Mr. Miles D. White M.B.A., Exec. Chairman (Age 66, Pay $6.97M)
Mr. Robert B. Ford, CEO, Pres, COO & Director (Age 47, Pay $2.63M)
Mr. Daniel Gesua Sive Salvadori, Exec. VP of Nutritional Products (Age 42, Pay $1.67M)
Ms. Lisa D. Earnhardt, Exec. VP of Medical Devices (Age 51, Pay $1.33M)
Mr. Robert E. Funck Jr., Exec. VP of Fin. & CFO (Age 60)
Mr. Scott Michael Leinenweber, VP of Investor Relations, Licensing & Acquisitions (Age 49)
Mr. Hubert L. Allen, Exec. VP, Gen. Counsel & Sec. (Age 55)
James E. Young, VP and Chief Ethics & Compliance Officer
Ms. Melissa Brotz, VP of Public Affairs & Corp. Marketing
Ms. Elaine R. Leavenworth, Sr. VP and Chief Marketing & External Affairs Officer (Age 62)
183 employees have rated Abbott Laboratories CEO Robert Ford on Glassdoor.com. Robert Ford has an approval rating of 89% among Abbott Laboratories’ employees.
Some companies that are related to Abbott Laboratories include Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD), Varian Medical Systems (VAR) and STERIS (STE).
Visualizza tutti i concorrenti di ABT.
1 | | Deposito minimo $50 Promozione esclusiva | Il nostro punteggio 10 ★★★★★ | 0% commissione |
Based on aggregate information from Reportlab watchlists, some companies that other Abbott Laboratories investors own include AbbVie (ABBV), Johnson & Johnson (JNJ), NVIDIA (NVDA), AT&T (T), Pfizer (PFE), The Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), The Home Depot (HD) and Verizon Communications (VZ).
Abbott Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol “ABT.”
Abbott Laboratories’ stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.53%), Fisher Asset Management LLC (0.42%), Swiss National Bank (0.39%), Sumitomo Mitsui Trust Holdings Inc. (0.33%), California Public Employees Retirement System (0.23%) and Bahl & Gaynor Inc. (0.15%). Company insiders that own Abbott Laboratories stock include Andrea F Wainer, Andrew H Lane, Brian B Yoor, Brian J Blaser, Christopher J Scoggins, Daniel Gesua Sive Salvadori, Hubert L Allen, Jaime Contreras, Jared Watkin, John F Ginascol, John M Capek, Joseph J Manning, Lisa D Earnhardt, Mary K Moreland, Michael D Dale, Michael J Pederson, Miles D White, Phebe N Novakovic, Philip P Boudreau, Randel William Woodgrift, Robert E Funck, Roger Bird, Roxanne S Austin, Sally E Blount, Sharon J Bracken and Stephen R Fussell.
View institutional ownership trends for Abbott Laboratories.
ABT stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Boston Partners, Sumitomo Mitsui Trust Holdings Inc., PGGM Investments, Swiss National Bank, Jennison Associates LLC, Candriam Luxembourg S.C.A., and Strs Ohio. Company insiders that have sold Abbott Laboratories company stock in the last year include Andrea F Wainer, Andrew H Lane, Christopher J Scoggins, Daniel Gesua Sive Salvadori, Jared Watkin, John F Ginascol, Joseph J Manning, Lisa D Earnhardt, Mary K Moreland, Michael D Dale, Michael J Pederson, Phebe N Novakovic, Philip P Boudreau, Randel William Woodgrift, Robert E Funck, Roger Bird, and Roxanne S Austin.
View insider buying and selling activity for Abbott Laboratories or view top insider-selling stocks.
ABT stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., First Trust Advisors LP, Comerica Bank, Milestone Resources Group Ltd, Fisher Asset Management LLC, Dearborn Partners LLC, Ingalls & Snyder LLC, and Robeco Institutional Asset Management B.V..
View insider buying and selling activity for Abbott Laboratories or or view top insider-buying stocks.
Shares of ABT can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Recensione di Interactive Brokers, Recensione di eToro, Recensione di DEGiro, Recensione di AvaTrade, Recensione di IG Markets, Rassegna dei mercati IC, Recensione di CMC Markets, Recensione di Admiral Markets e molti altri. Legga una delle recensioni per scoprire tutto sul broker e inizi a comprare azioni ora.
A Reportlab.org vogliamo assicurarci che lei abbia tutte le informazioni più rilevanti su acquisto di azioni. Le portiamo le migliori guide sul mercato azionario con recensioni personali, informazioni di base, recensioni di piattaforme, how to's e altro. Vuole ottenere altre informazioni? Allora dia un'occhiata al Azioni OTC, Azioni del NASDAQ, Azioni del NYSE, Azioni LON, Scorte FRA, Azioni ETR, Scorte dell'EPA, Azioni del TSX o Azioni Amex. Cercando informazioni più dettagliate come 5g stock, azioni biotecnologiche, azioni d'oro e altre informazioni dal nostro reportlab.
How to buy Abbott Laboratories stocks?
The safest and easiest way to buy NYSE:ABT stocks is by using a regulated broker like eToro or DEGiro. You can open an account with the platform, make a deposit and buy this stock in under 5 minutes from start to finish.
Aprire un conto con uno di questi broker è una mossa intelligente, sono attivi da più di 10 anni, sono molto sicuri da usare e hanno la migliore piattaforma per trader principianti ed esperti. Se vuole saperne di più, le consigliamo di leggere il nostro eToro o DeGiro guide.
Where to buy Abbott Laboratories stock?
You will first want to find a licensed broker that supports Abbott Laboratories stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NYSE:ABT stocks in a safe and complete environment.
Is NYSE:ABT stock a good investment?
As with any other asset, there is an element of risk associated with buying NYSE:ABT stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Abbott Laboratories stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NYSE:ABT is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Abbott Laboratories stock.
How do you trade Abbott Laboratories stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Abbott Laboratories stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NYSE:ABT stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Abbott Laboratories stock?
To sell your NYSE:ABT stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Abbott Laboratories stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NYSE:ABT stock.
Stephen conosce molto bene i prodotti finanziari e in particolare ha una grande passione per i mercati azionari e i suoi partecipanti. Speriamo che le informazioni fornite le siano utili. C'è qualcosa di poco chiaro? Lasci le sue domande o commenti in fondo alla pagina.
| Il nostro punteggio ★★★★★ | |
| Il nostro punteggio ★★★★★ | |
| Il nostro punteggio ★★★★★ |
Notiziario
Notizie recenti
| |
Il nostro punteggio |
0% commissione |
Dati in tempo reale su azioni e criptovalute
Notifiche, Consigli e Notizie
Le migliori guide su azioni e criptovalute
Recensioni su broker e scambi online
Reportlab Finanza è un sito web puramente informativo e non implica in nessun caso consigli di investimento. Tutti gli investimenti comportano rischi e lei può perdere tutti i suoi investimenti. Non investa denaro che non può permettersi di perdere.
Reportlab Finanza
38 Holburn Lane
Heckfield Green
IP21 0UB
Regno Unito
Copyright © 2022 Reportlab.Finance | Tutti i diritti riservati.
